Study identifies patients with obesity most likely to benefit from GLP-1-based treatment
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a potential answer by identifying a distinct biological…
Read the full articleYou might also wanna read
Study Identifies Patients with Obesity Most Likely to Benefit From GLP-1-Based Treatment
Why do some people lose substantial weight with GLP-1-based medications while others see more modest results? A Mayo Clinic study offers a p
Tirzepatide
Your Daily, No-Needle Weight Loss Solution Targets both GLP-1 and GIP pathways Supports weight loss and satiety Conveniently place tablet un
twc.health·17d agoTirzepatide
Your Daily, No-Needle Weight Loss Solution Targets both GLP-1 and GIP pathways Supports weight loss and satiety Conveniently place tablet un
twc.health·17d ago
New GLP-1 Drug Promotes Weight Loss in Obesity
A new strategy for delivering GLP-1 drugs to patients with obesity or who were overweight resulted in up to an 11 percent reduction in body
Study: Most Patients Regain Weight and Lose Health Benefits After Stopping GLP-1 Drugs
In trial, 82% saw weight rebound and cardiovascular health reverse after withdrawal.
arstechnica.com·7mo ago
Tirzepatide vs. Semaglutide
Both are GLP-1 medications that are FDA-approved for Type 2 diabetes and weight loss, but how they work differs
Can New Drugs Help Millions of Americans with Obesity?
Can New Drugs Help Millions of Americans with Obesity? Olivia Farrar Mon, 09/30/2024 - 12:01 More than 100 million Americans struggle with o
Comments
Sign in to join the conversation.
No comments yet. Be the first.